Berliner Tageszeitung - MEP Calls for EU-Wide Equity in Cancer Screening After Personal Skin Cancer Battle

A Member of the European Parliament is calling for immediate action to address deep-seated inequalities in cancer screening and diagnosis across Europe, drawing on her personal experience with a treatable but recurring form of skin cancer. Her intervention coincides with a critical vote in the European Parliament today on a report reviewing the implementation of the EU Beating Cancer Plan.

The MEP’s advocacy is rooted in a medical journey that began approximately ten years ago during a routine physiotherapy appointment. A therapist noticed an anomaly on her back, prompting an immediate referral for a checkup. Subsequent biopsy results confirmed a diagnosis of basal cell carcinoma, a common and highly treatable form of skin cancer that does not spread like melanoma.

Despite the benign nature of the initial diagnosis, the condition required six surgical procedures to remove the cancer from her back. She notes that she has never used sunbeds, attributing her condition to exposure to the Irish sun. Her experience underscores a broader public health reality: skin cancer is the most common form of cancer in Ireland, with more than 12,500 new cases diagnosed annually. Projections indicate this figure could double by 2040.

While early detection can cure up to 90% of skin cancer cases, access to such screening remains highly inconsistent across the European Union. The recent death of European athletic champion Ciara Mageean from bowel cancer at age 34 has intensified calls for a national conversation in Ireland regarding cancer awareness and healthcare resources. This concern extends beyond Irish borders, as cancer remains one of Europe’s leading causes of death.

The report currently under review by the European Parliament acknowledges progress made since the launch of the EU Beating Cancer Plan in 2021, which was backed by €4 billion in funding. However, it emphasizes that success must be measured by patient outcomes rather than the number of initiatives launched. The report highlights that the EU’s 2021 target to offer breast, cervical, and colorectal cancer screening to 90% of eligible people by 2025 was not met.

Significant disparities persist in timely diagnosis and treatment across member states. For instance, participation rates for mammography among women aged 50 to 69 vary drastically, ranging from 83% in Denmark to just 9% in Romania. The report calls for stronger national screening programs, improved access to diagnostic technologies, and greater investment in early detection to ensure that a person’s survival chances are not determined by their geographic location.

These disparities are particularly pronounced within Ireland itself. Data indicates that people living in the most deprived areas of Ireland face a 28% higher risk of dying from cancer compared to those in affluent areas. The gap is even wider in Northern Ireland, where the mortality risk difference stands at 45%. Ciara Mageean was from Northern Ireland.

In light of these findings, the report advocates for at least €2.5 billion to be dedicated to cancer-related actions in the EU’s next seven-year budget. The Irish Presidency, which is currently negotiating this budget, is urged to act as a pioneer in European cancer policy. The MEP argues that this investment is necessary not only to honor Mageean but to ensure more lives are saved through equitable care.

The report concludes that while the upcoming vote will not instantly cure cancer or solve all related challenges, it offers a vital opportunity to reaffirm that early detection, prevention, and equal access to care must remain central to the EU’s cancer strategy. The MEP urges the public to perform regular self-checks for breast, bowel, and skin cancer, emphasizing the importance of consulting approved health advice websites and seeking medical attention for any concerns.

Reflecting on her own survival, the MEP expressed profound gratitude for the alertness of her physiotherapist, who identified the early signs of her condition. She urges the public to remain equally vigilant, noting that relying on luck is not a sustainable strategy for cancer prevention.

F. Burkhard--BTZ